Edgestream Partners L.P. Sells 13,207 Shares of Avantor, Inc. (NYSE:AVTR)

Edgestream Partners L.P. lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 27.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,367 shares of the company’s stock after selling 13,207 shares during the quarter. Edgestream Partners L.P.’s holdings in Avantor were worth $750,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. CCLA Investment Management increased its position in shares of Avantor by 147,220.3% during the first quarter. CCLA Investment Management now owns 4,720,144 shares of the company’s stock worth $120,828,000 after acquiring an additional 4,716,940 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Avantor in the fourth quarter valued at approximately $93,433,000. Avidity Partners Management LP purchased a new position in shares of Avantor during the fourth quarter valued at approximately $48,442,000. Magnetar Financial LLC bought a new stake in Avantor during the first quarter worth $35,154,000. Finally, Jennison Associates LLC raised its position in Avantor by 113.0% in the 1st quarter. Jennison Associates LLC now owns 2,497,349 shares of the company’s stock valued at $63,857,000 after buying an additional 1,325,026 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is owned by company insiders.

Avantor Price Performance

Shares of NYSE:AVTR opened at $26.99 on Friday. The firm has a market capitalization of $18.33 billion, a PE ratio of 69.21, a P/E/G ratio of 2.75 and a beta of 1.32. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. The company has a 50-day moving average price of $25.04 and a two-hundred day moving average price of $24.36. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $28.00.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Friday, July 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. Equities analysts forecast that Avantor, Inc. will post 1.01 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Stifel Nicolaus upped their target price on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Wells Fargo & Company assumed coverage on shares of Avantor in a research report on Tuesday, August 27th. They set an “overweight” rating and a $30.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and issued a $31.00 target price on shares of Avantor in a research note on Monday, July 29th. Citigroup lowered Avantor from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $30.00 to $23.00 in a report on Wednesday, July 10th. Finally, Evercore ISI reduced their price objective on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 2nd. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $27.40.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.